Patents by Inventor Paul Q. Anziano

Paul Q. Anziano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130289123
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Application
    Filed: March 28, 2013
    Publication date: October 31, 2013
    Applicant: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Patent number: 8426644
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: April 23, 2013
    Assignee: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Patent number: 8324279
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as heart failure.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: December 4, 2012
    Assignee: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Publication number: 20120059064
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Application
    Filed: June 28, 2011
    Publication date: March 8, 2012
    Applicant: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Patent number: 7989499
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Grant
    Filed: February 8, 2006
    Date of Patent: August 2, 2011
    Assignee: MitoTek, LLC
    Inventor: Paul Q. Anziano
  • Publication number: 20100199367
    Abstract: A new isoform of manganese superoxide dismutase (MnSOD) and polynucleotides encoding it have been identified. This isoform, MnSOD E3(?), is a splice variant lacking exon 3 of the full length MnSOD. The polypeptide can be expressed using appropriate host cells. Modulation of either the expression of the polynucleotides of the activity of the polypeptide is also described. Furthermore, diagnostic and therapeutic methods have been developed as a consequence of the isolation of the polynucleotides and polypeptides.
    Type: Application
    Filed: June 4, 2007
    Publication date: August 5, 2010
    Inventor: Paul Q. Anziano
  • Publication number: 20100028348
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as heart failure.
    Type: Application
    Filed: September 17, 2009
    Publication date: February 4, 2010
    Applicant: MITOTEK, LLC
    Inventor: Paul Q. Anziano
  • Publication number: 20080287548
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as neurodegenerative diseases and heart failure.
    Type: Application
    Filed: February 8, 2006
    Publication date: November 20, 2008
    Inventor: Paul Q. Anziano
  • Patent number: 7227001
    Abstract: A new isoform of manganese superoxide dismutase (MnSOD) and polynucleotides encoding it have been identified. This isoform, MnSOD E3(?), is a splice variant lacking exon 3 of the full length MnSOD. The polypeptide can be expressed using appropriate host cells. Modulation of either the expression of the polynucleotides of the activity of the polypeptide is also described. Furthermore, diagnostic and therapeutic methods have been developed as a consequence of the isolation of the polynucleotides and polypeptides.
    Type: Grant
    Filed: April 4, 2005
    Date of Patent: June 5, 2007
    Inventor: Paul Q. Anziano
  • Patent number: 7144994
    Abstract: A new isoform of manganese superoxide dismutase (MnSOD) and polynucleotides encoding it have been identified. This isoform, MnSOD E3(?), is a splice variant lacking exon 3 of the full length MnSOD. The polypeptide can be expressed using appropriate host cells. Modulation of either the expression of the polynucleotides of the activity of the polypeptide is also described. Furthermore, diagnostic and therapeutic methods have been developed as a consequence of the isolation of the polynucleotides and polypeptides.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: December 5, 2006
    Inventor: Paul Q. Anziano
  • Publication number: 20040242655
    Abstract: The present invention is directed to methods of modulating the activity of an isoform of manganese superoxide dismutase which is useful for the treatment of diseases such as heart failure.
    Type: Application
    Filed: May 28, 2004
    Publication date: December 2, 2004
    Inventor: Paul Q. Anziano
  • Publication number: 20040152115
    Abstract: A new isoform of manganese superoxide dismutase (MnSOD) and polynucleotides encoding it have been identified. This isoform, MnSOD E3(−), is a splice variant lacking exon 3 of the full length MnSOD. The polypeptide can be expressed using appropriate host cells. Modulation of either the expression of the polynucleotides of the activity of the polypeptide is also described. Furthermore, diagnostic and therapeutic methods have been developed as a consequence of the isolation of the polynucleotides and polypeptides.
    Type: Application
    Filed: January 7, 2004
    Publication date: August 5, 2004
    Inventor: Paul Q. Anziano
  • Patent number: 6737506
    Abstract: An isoform of manganese superoxide dismutase (MnSOD) and polynucleotides encoding it have been identified. This isoform, MnSOD E3(−), is a splice variant lacking exon 3 of the full length MnSOD. The polypeptide can be expressed using appropriate host cells. Modulation of either the expression of the polynucleotides or the activity of the polypeptide is also described. Furthermore, diagnostic and therapeutic methods have been developed as a consequence of the isolation of the polynucleotides and polypeptides.
    Type: Grant
    Filed: January 16, 2001
    Date of Patent: May 18, 2004
    Inventor: Paul Q. Anziano